198 related articles for article (PubMed ID: 11026653)
1. Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril.
Pawlak R; Chabielska E; Matys T; Kucharewicz I; Rółkowski R; Buczko W
J Cardiovasc Pharmacol; 2000 Oct; 36(4):503-9. PubMed ID: 11026653
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effect of captopril and enalapril in young rats.
Buczko W; Kubik A; Kucharewicz I; Chabielska E
Pol J Pharmacol; 2004; 56(1):97-104. PubMed ID: 15047983
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
Kucharewicz I; Pawlak R; Matys T; Pawlak D; Buczko W
Hypertension; 2002 Nov; 40(5):774-9. PubMed ID: 12411476
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
Wojewódzka-Zelezniakowicz M; Chabielska E; Mogielnicki A; Kramkowski K; Karp A; Opadczuk A; Domaniewski T; Malinowska-Zaprzałka M; Buczko W
J Physiol Pharmacol; 2006 Jun; 57(2):231-45. PubMed ID: 16845228
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Hermanowicz JM; Hermanowicz A; Buczko P; Leszczynska A; Tankiewicz-Kwedlo A; Mogielnicki A; Buczko W
Thromb Res; 2013 Jan; 131(1):e39-44. PubMed ID: 23174623
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
8. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Bernátová I; Pechánová O; Simko F
Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
[TBL] [Abstract][Full Text] [Related]
9. Propofol increases vascular relaxation in aging rats chronically treated with the angiotensin-converting enzyme inhibitor captopril.
Gragasin FS; Bourque SL; Davidge ST
Anesth Analg; 2013 Apr; 116(4):775-83. PubMed ID: 23429803
[TBL] [Abstract][Full Text] [Related]
10. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
11. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
12. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I
Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Khattab MM; Mostafa A; Al-Shabanah O
Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
[TBL] [Abstract][Full Text] [Related]
15. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
[TBL] [Abstract][Full Text] [Related]
16. Losartan inhibits experimental venous thrombosis in spontaneously hypertensive rats.
Chabielska E; Pawlak R; Golatowski J; Rółkowski R; Pawlak D; Buczko W
Thromb Res; 1998 Jun; 90(6):271-8. PubMed ID: 9700857
[TBL] [Abstract][Full Text] [Related]
17. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
Liu YH; Liu LY; Wu JX; Chen SX; Sun YX
J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effect of enalapril, an angiotensin-converting enzyme inhibitor, on venous thrombosis in rats.
Pawlak R; Chabielska E; Buczko W
Pol J Pharmacol; 1996; 48(1):117-20. PubMed ID: 9112640
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
Ying L; Flamant M; Vandermeersch S; Boffa JJ; Chatziantoniou C; Dussaule JC; Chansel D
Hypertension; 2003 Nov; 42(5):937-44. PubMed ID: 14569001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
